We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

By LabMedica International staff writers
Posted on 01 Oct 2024
Print article
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide quicker results but often lack the sensitivity and accuracy of PCR. Now, a new method that combines confocal fluorescence microscopy with microfluidic laminar flow marks a significant advancement in virus detection. Unlike traditional PCR, this innovative approach can rapidly detect individual virus particles cost-effectively, using a 3D-printed microscopy technology called Brick-MIC. This method boosts both sensitivity and specificity in virus detection, potentially transforming how viral outbreaks are monitored and managed. Its portable and user-friendly design makes it well-suited for wider clinical applications, strengthening public health responses to emerging viral challenges.

The breakthrough virus detection method developed by a group of researchers that included scientists from The Hebrew University of Jerusalem (Rehovot, Israel) uses laminar flow in a microfluidic channel along with fluorescence signals from free dyes and labeled antibodies to reveal key characteristics of nanoparticles. The team demonstrated the method's accuracy by testing it on fluorescent beads and various viruses, including the SARS-CoV-2 Spike protein. One of the key elements of this new assay is the use of hydrodynamic focusing, which significantly enhances sensitivity, enabling virus detection at clinically relevant concentrations.

Its portability and the use of the affordable 3D-printed Brick-MIC setup make it accessible for clinical environments. This innovation signals a shift toward rapid and precise virus detection, in line with personalized healthcare principles. By enabling fast, specific identification of viruses, this technology could help tailor medical interventions to individual patient needs, improving the timeliness and effectiveness of treatments. The research was published in iScience, with the 3D-printed microscopy approach detailed in Science Advances.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.